209 related articles for article (PubMed ID: 26007286)
1. Activation of hepatic CREBH and Insig signaling in the anti-hypertriglyceridemic mechanism of R-α-lipoic acid.
Tong X; Christian P; Zhao M; Wang H; Moreau R; Su Q
J Nutr Biochem; 2015 Sep; 26(9):921-8. PubMed ID: 26007286
[TBL] [Abstract][Full Text] [Related]
2. Glucagon regulates hepatic lipid metabolism via cAMP and Insig-2 signaling: implication for the pathogenesis of hypertriglyceridemia and hepatic steatosis.
Wang H; Zhao M; Sud N; Christian P; Shen J; Song Y; Pashaj A; Zhang K; Carr T; Su Q
Sci Rep; 2016 Sep; 6():32246. PubMed ID: 27582413
[TBL] [Abstract][Full Text] [Related]
3. Insulin enhances the biogenesis of nuclear sterol regulatory element-binding protein (SREBP)-1c by posttranscriptional down-regulation of Insig-2A and its dissociation from SREBP cleavage-activating protein (SCAP).SREBP-1c complex.
Yellaturu CR; Deng X; Park EA; Raghow R; Elam MB
J Biol Chem; 2009 Nov; 284(46):31726-34. PubMed ID: 19759400
[TBL] [Abstract][Full Text] [Related]
4. Overexpression of Insig-1 protects β cell against glucolipotoxicity via SREBP-1c.
Chen K; Jin P; He HH; Xie YH; Xie XY; Mo ZH
J Biomed Sci; 2011 Aug; 18(1):57. PubMed ID: 21843373
[TBL] [Abstract][Full Text] [Related]
5. Very Low Density Lipoprotein Assembly Is Required for cAMP-responsive Element-binding Protein H Processing and Hepatic Apolipoprotein A-IV Expression.
Cheng D; Xu X; Simon T; Boudyguina E; Deng Z; VerHague M; Lee AH; Shelness GS; Weinberg RB; Parks JS
J Biol Chem; 2016 Nov; 291(45):23793-23803. PubMed ID: 27655915
[TBL] [Abstract][Full Text] [Related]
6. Hepatic insig-1 or -2 overexpression reduces lipogenesis in obese Zucker diabetic fatty rats and in fasted/refed normal rats.
Takaishi K; Duplomb L; Wang MY; Li J; Unger RH
Proc Natl Acad Sci U S A; 2004 May; 101(18):7106-11. PubMed ID: 15096598
[TBL] [Abstract][Full Text] [Related]
7. cAMP response element binding protein H mediates fenofibrate-induced suppression of hepatic lipogenesis.
Min AK; Jeong JY; Go Y; Choi YK; Kim YD; Lee IK; Park KG
Diabetologia; 2013 Feb; 56(2):412-22. PubMed ID: 23150180
[TBL] [Abstract][Full Text] [Related]
8. Phytoceuticals in Fenugreek Ameliorate VLDL Overproduction and Insulin Resistance via the Insig Signaling Pathway.
Khound R; Shen J; Song Y; Santra D; Su Q
Mol Nutr Food Res; 2018 Mar; 62(5):. PubMed ID: 29210166
[TBL] [Abstract][Full Text] [Related]
9. Silibinin protects β cells from glucotoxicity through regulation of the Insig-1/SREBP-1c pathway.
Chen K; Zhao L; He H; Wan X; Wang F; Mo Z
Int J Mol Med; 2014 Oct; 34(4):1073-80. PubMed ID: 25109869
[TBL] [Abstract][Full Text] [Related]
10. Comparison of in vivo effects of insulin on SREBP-1c activation and INSIG-1/2 in rat liver and human and rat adipose tissue.
Boden G; Salehi S; Cheung P; Homko C; Song W; Loveland-Jones C; Jayarajan S
Obesity (Silver Spring); 2013 Jun; 21(6):1208-14. PubMed ID: 23913732
[TBL] [Abstract][Full Text] [Related]
11. A novel processing system of sterol regulatory element-binding protein-1c regulated by polyunsaturated fatty acid.
Nakakuki M; Kawano H; Notsu T; Imada K; Mizuguchi K; Shimano H
J Biochem; 2014 May; 155(5):301-13. PubMed ID: 24729033
[TBL] [Abstract][Full Text] [Related]
12. Lipoic acid improves hypertriglyceridemia by stimulating triacylglycerol clearance and downregulating liver triacylglycerol secretion.
Butler JA; Hagen TM; Moreau R
Arch Biochem Biophys; 2009 May; 485(1):63-71. PubMed ID: 19232511
[TBL] [Abstract][Full Text] [Related]
13. Reversal of obesity-induced hypertriglyceridemia by (R)-α-lipoic acid in ZDF (fa/fa) rats.
Yi X; Pashaj A; Xia M; Moreau R
Biochem Biophys Res Commun; 2013 Sep; 439(3):390-5. PubMed ID: 23994635
[TBL] [Abstract][Full Text] [Related]
14. CREBH mediates metabolic inflammation to hepatic VLDL overproduction and hyperlipoproteinemia.
Song Y; Zhao M; Cheng X; Shen J; Khound R; Zhang K; Su Q
J Mol Med (Berl); 2017 Aug; 95(8):839-849. PubMed ID: 28455595
[TBL] [Abstract][Full Text] [Related]
15. Activation of PPARalpha and PPARgamma reduces triacylglycerol synthesis in rat hepatoma cells by reduction of nuclear SREBP-1.
König B; Koch A; Spielmann J; Hilgenfeld C; Hirche F; Stangl GI; Eder K
Eur J Pharmacol; 2009 Mar; 605(1-3):23-30. PubMed ID: 19248225
[TBL] [Abstract][Full Text] [Related]
16. Liver-specific mRNA for Insig-2 down-regulated by insulin: implications for fatty acid synthesis.
Yabe D; Komuro R; Liang G; Goldstein JL; Brown MS
Proc Natl Acad Sci U S A; 2003 Mar; 100(6):3155-60. PubMed ID: 12624180
[TBL] [Abstract][Full Text] [Related]
17. Dietary protein restriction reduces circulating VLDL triglyceride levels via CREBH-APOA5-dependent and -independent mechanisms.
Treviño-Villarreal JH; Reynolds JS; Bartelt A; Langston PK; MacArthur MR; Arduini A; Tosti V; Veronese N; Bertozzi B; Brace LE; Mejia P; Trocha K; Kajitani GS; Longchamp A; Harputlugil E; Gathungu R; Bird SS; Bullock AD; Figenshau RS; Andriole GL; Thompson A; Heeren J; Ozaki CK; Kristal BS; Fontana L; Mitchell JR
JCI Insight; 2018 Nov; 3(21):. PubMed ID: 30385734
[TBL] [Abstract][Full Text] [Related]
18. GLP-1 Elicits an Intrinsic Gut-Liver Metabolic Signal to Ameliorate Diet-Induced VLDL Overproduction and Insulin Resistance.
Khound R; Taher J; Baker C; Adeli K; Su Q
Arterioscler Thromb Vasc Biol; 2017 Dec; 37(12):2252-2259. PubMed ID: 29074588
[TBL] [Abstract][Full Text] [Related]
19. Limited role for SREBP-1c in defective glucose-induced insulin secretion from Zucker diabetic fatty rat islets: a functional and gene profiling analysis.
Parton LE; McMillen PJ; Shen Y; Docherty E; Sharpe E; Diraison F; Briscoe CP; Rutter GA
Am J Physiol Endocrinol Metab; 2006 Nov; 291(5):E982-94. PubMed ID: 16772326
[TBL] [Abstract][Full Text] [Related]
20. Peroxisome proliferator-activated receptor-delta induces insulin-induced gene-1 and suppresses hepatic lipogenesis in obese diabetic mice.
Qin X; Xie X; Fan Y; Tian J; Guan Y; Wang X; Zhu Y; Wang N
Hepatology; 2008 Aug; 48(2):432-41. PubMed ID: 18627005
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
